About
Discriminate Staining Platform for Cancer Detection
Zetiq has developed a proprietary platform, CellDetect, for the detection of cancer cells via discriminate staining of cancer cells among normal cells, preserving the morphological features of the cells. The platform technology enables color discrimination between red cancer cells and green non-cancer cells. Using a simple, in-vitro procedure to stain cells, Zetiq offers dual-color and morphological diagnostic products thatcan save resources and are amenable to automation, fora wide range of cancer indications. Products originating from the CellDetectplatform have achieved positive results in targeted clinical trials. Zetiq is a wholly-owned subsidiary of Micromedic and BioLight.
Identity
| Name | Zetiq Technologies |
|---|---|
| Slug | zetiq-technologies24 |
| Type / kind | startup |
| Crunchbase ID | zetiq-technologies |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7igesJDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Micromedic on Jun 2011 - closed due to acquisition |
| Last update | 2026-05-17 |
Web & social
| https://www.linkedin.com/company/zetiq-technologies-ltd- |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareLaboratoriesProviders
Business models
B2B
Tags
medical-technologiesbiotechnologyoncologydiagnosticscancercellsclinicslaboratories
Funding
| Total raised | — |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}